Preclinical evaluation of RM-042, an orally bioavailable inhibitor of GTP-RAS, in models of pancreatic ductal adenocarcinoma

Urszula N. Wasko, Stephen A. Sastra, Carmine F. Palermo, David Wildes, Mallika Singh, Kenneth P. Olive

 

American Association for Cancer Research (AACR) Annual Meeting 2023; April 16-19, 2023

 

Download poster

 

 

Return to Media Home